5-Fluorouracil-loaded microspheres prepared by spray-drying poly(D,L-lactide) and poly(lactide-co-glycolide) polymers: Characterization and drug release

References

• Anderson JM, Shive MS. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 28:5–24.
   PubMed Web of Science ®Google Scholar
• Bath DF, Munday DL, Smith A. 1999a. Modulation of rifampicin release from spray-dried microspheres using combinations of poly-(DL-lactide). Journal of Microencapsulation 16:369–385.
   PubMedGoogle Scholar
• Bath DF, Munday DL, Smith A. 1999b. Solvent influence on spray-dried biodegradable microspheres. Journal of Microencapsulation 16:453–474.
   PubMed Web of Science ®Google Scholar
• Benoit JP, Faisant N, Venier-Julienne MC, Menei P. 2000. Development of microspheres for neurological disorders: From basics to clinical applications. Journal of Controlled Release 65:285–296.
   PubMedGoogle Scholar
• Benoit MA, Baras B, Gillard J. 1999. Preparation and characterization of protein-loaded poly(s-caprolactone) microparticles for oral vaccine delivery. International Journal of Pharmaceutics 184:73–84.
   PubMed Web of Science ®Google Scholar
• Blanco MD, Garcia O, Gómez C, Sastre RL, Teijón JM. 2000. In vivo drug delivery of 5-fluorouracil using poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels. Journal of Pharmaceutics & Pharmacology 52:1319–1325.
   PubMedGoogle Scholar
• Blanco MD, Garcia O, Trigo RM, Teijon JM, Katime I. 1996.5-Fluorouracil release from copolymeric hydrogels of itaconic acid monoester. I. Acrylamide-co-monomethyl itaconate. Biomaterials 17:1061–1067.
   PubMedGoogle Scholar
• Blanco-Prieto MJ, Besseghir K, Orsolini P, Heimgartner F, Deuschel C, Merlde HP, Nam-Tran H, Gander B. 1999. Importance of the test medium for the release kinetics of a somatostatin analogue from poly(D,L-lactide-co-glycolide) microspheres. International Journal of Pharmaceutics 184:243–250.
   PubMedGoogle Scholar
• Bouhadir KH, Alsberg E, Mooney DJ. 2001. Hydrogels for combination delivery of antineoplastic agents. Biomaterials 22:2625–2633.
   PubMedGoogle Scholar
• Buckpitt AR, Boyd MR. 1980. A sensitive method for determination of 5-fluorouracil and 5-fluoro-2'-deoxyuridine in human plasma by high-pressure liquid chromatography. Analytical Biochemistry 106:432–437.
   PubMedGoogle Scholar
• Cadee JA, Brouwer LA, den Otter W, Hennink WE, van Luyn MJA. 2001. A comparative biocompatibility study of micropheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. Journal of Biomedical Materials Research 56:600–609.
   PubMedGoogle Scholar
• Denizli A, Kiremitci M, Piskin E. 1988a. Subcutaneous polymeric matrix system poly(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil): I. Synthesis and structure. Biomaterials 9:257–262.
   PubMedGoogle Scholar
• Denizli A, Kiremitci M, Piskin E. 1988b. Subcutaneous polymeric matrix system p(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil): II. Release kinetics. Biomaterials 9:363–366.
   PubMedGoogle Scholar
• Dickson, JLB, Cunningham D. 2004. Systemic treatment of gastric cancer. European Journal of Gastroenterology & Hepatology 16:255–263.
   PubMedGoogle Scholar
• Dolinsky A. 2001. High-temperature spray drying. Drying Technology 19:785–807.
   Google Scholar
• Dunne M, Corrigan CH, Ramtoola Z. 2000. Influence of particle size and dissolution conditions on the degradation properties of polylactide-co-glycolide particles. Biomaterials 21:1659–1668.
   PubMedGoogle Scholar
• Earl H, Iddawela M. 2004. Epirubicin as adjuvant therapy in breast cancer. Expert Reviews in Anticancer Therapy 4:189–195.
   PubMedGoogle Scholar
• Freiberg S, Zhu X. 2004. Polymer microspheres for controlled drug release. International Journal of Pharmaceutics 282:1–18.
   PubMedGoogle Scholar
• Fu YJ, Mi FL, Wong TB, Shyu SS. 2001. Characteristics and controlled release of anticancer drug loaded poly(D,L-lactide) microparticles prepared by spray drying technique. Journal of Microencapsulation 18:733-747. Fung LK, Saltzman WM. 1997. Polymeric implants for cancer chemotherapy. Advanced Drug Delivery Reviews 26:209–230.
   Google Scholar
• Garcia O, Blanco MD, Martin JA, Teijon JM. 2000.5-Fluorouracil trapping in poly(2-hydroxyethyl methacrylate-co-acrylamide) hydrogels: In vitro drug delivery studies. European Polymer Journal 36:111–122.
   Google Scholar
• Goldberg RM. 2004. Current approaches to first-line treatment of advanced colorectal cancer. Clinical Colorectal Cancer 4(Suppl 1):59–515.
   Google Scholar
• Gomez C, Blanco MD, Bernardo MV, Olmo R, Muniz E, Teijón JM. 2004. Cytarabine release from comatrices of albumin microspheres in a poly(lactide-co-glycolide) film: In vitro and in vivo studies. European Journal of Pharmaceutics & Biopharmaceutics 57:225–233.
   PubMedGoogle Scholar
• Gutman RL, Peacock G, Lu DR. 2000. Targeted drug delivery for brain cancer treatment. Journal of Controlled Release 65:31–41.
   PubMedGoogle Scholar
• Jeyanthi R, Nagarajan B, Rao KP. 1991. Solid tumour chemotherapy using implantable collagen-poly (HEMA) hydrogel containing 5-fluorouracil. Journal of Pharmaceutics & Pharmacology 43:60–62.
   PubMedGoogle Scholar
• Jones E. 1996. Methylene chloride, an overview of human and enviromental effects. Pharmaceutical Technology in Europe 8:30–32.
   Google Scholar
• Jorizzo J. 2004. Topical treatment of actinic keratosis with fluorouracil: Is irritation associated with efficacy? Journal of Drugs in Dermatology 3:21–26.
   PubMedGoogle Scholar
• Kim ES, Glisson BS. 2003. Treatment of metastatic head and neck cancer: Chemotherapy and novel agents. Cancer Treatment Research 114:295–314.
   PubMedGoogle Scholar
• Lamprecht A, Yamamoto H, Takeuchi H, Kawashima Y. 2003. Microsphere design for the colonic delivery of 5-fluorouracil. Journal of Controlled Release 90:313–322.
   PubMedGoogle Scholar
• Lee JS, Chae GS, Kim MS, Cho SH, Lee HB, Khang G. 2004. Degradation behaviour in vitro for poly(D,L-lactide-co-glycolide) as drug carrier. Bio-Medical Materials Engineering 14:185–192.
   PubMedGoogle Scholar
• Longley DB, Harkin DP, Johnston PG. 2003.5-fluorouracil: Mechanisms of action and clinical strategies. Nature Reviews in Cancer 3:330–338.
   PubMedGoogle Scholar
• Luck M, Pistel KF, Li YX, Blunk T, Muller RH, Kissel T. 1998. Plasma protein adsorption on biodegradable microspheres consisting of poly(D,L-lactide-co-glycolide), poly(L-lactide) or ABA triblock copolymers containing poly(oxyethylene). Influence of production method and polymer composition. Journal of Controlled Release 55:107–120.
   PubMedGoogle Scholar
• Murillo M, Gamazo C, Gofii MM, Irache JM, Blanco-Prieto MJ. 2002. Development of microparticles prepared by spray-drying as a vaccine delivery system against brucellosis. International Journal of Pharmaceutics 24:341–344.
   Google Scholar
• Pasetto LM, Jirillo A, Stefani M, Monfardini S. 2004. Old and new drugs in systemic therapy of pancreatic cancer. Critical Reviews in Oncology & Hematology 49:135–151.
   PubMedGoogle Scholar
• Rothenberg ML. 2004. Current status of second-line therapy for metastatic colorectal cancer. Clinical Colorectal Cancer 4(Suppl 1):516–521.
   Google Scholar
• Roullin VG, L,emaire L, Venier-Julienne MC, Faisant N, Franconi F, Benoit JP. 2003. Release kinetics of 5-fluorouracil-loaded microspheres on an experimental rat glioma. Anticancer Research 23:21–25.
   PubMedGoogle Scholar
• Schimmel KJM, Richel DJ, van den Brink RBA, Guchelaar HJ. 2004. Cardiotoxicity of cytotoxic drugs. Cancer Treatment Reviews 30:181–191.
   PubMedGoogle Scholar
• Shi GX, Cai Q, Wang CY, Lu N, Wang SG, Bei JZ. 2002. Fabrication and biocompatibility of cell scaffolds of poly(L-lactic acid) and poly(L-lactic-co-glycolic acid). Polymer Advanced Technology13:227–232.
   Google Scholar
• Siepmann J, Faisant N, Akiki J, Richard J, Benoit JP. 2004. Effect of the size of biodegradable microparticles on drug release: Experiment and theory. Journal of Controlled Release 96:123–134.
   PubMedGoogle Scholar
• Sinha VR, Mittal BR, Bhutani KK, Kumria R. 2004. Colonic drug delivery of 5-fluorouracil: An in vitro evaluation. International Journal of Pharmaceutics 269:101–108.
   PubMedGoogle Scholar
• Tutrone WD, Saini R, Caglar S, Weinberg JM, Crespo J. 2003. Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod. Cutis; Cutaneous Medicine For The Practitioner 71:365–370.
   PubMedGoogle Scholar
• Wang FJ, Wang CH. 2003. Etanidazole-loaded microspheres fabricated by spray-drying different poly(lactide/glycolide) polymers: Effects on microsphere properties. Journal of Biomaterials Science, Polymer Edition 14:157–183.
   PubMedGoogle Scholar
• Yoshino T, Machida Y, Onishi H, Nagai T. 2003. Preparation and characterization of chitosan microspheres containing doxifluridine. Drug Developments in Industrial Pharmacy 29:417–427.
   PubMedGoogle Scholar
• Zhu KJ, Zhang JX, Wang C, Yasuda H, Ichimaru A, Yamamoto K. 2003. Preparation and in vitro release behaviour of 5-fluorouracil-loaded microspheres based on poly (L-lactide) and its carbonate copolymers. Journal of Microencapsulation 20:731–743.
   PubMedGoogle Scholar